Table 2.
Type of diabetes (n = 406) |
|
Type 1 |
12.8% |
Type 2 |
68.5% |
Undetermined |
18.7% |
Duration of the disease (n = 399) |
|
1-5 years |
28.3% |
6-10 years |
23.1% |
11-15 years |
17.3% |
≥16 years |
31.3% |
Type of treatment (n = 405) |
|
Oral antidiabetic drugs (OAD) |
49.6% |
Insulin |
22.7% |
Oral antidiabetic dugs and insulin |
26.9% |
None/unknown |
0.8% |
Glucose self-monitoring (n = 398) |
82% |
Diabetes complications (n = 396)† |
|
At least one |
46.7% |
Macrovascular complications* |
34.9% |
Microvascular** | 24% |
†: Myocardial infarction/angina, stroke, retinopathy (excluding cataract and glaucoma problems), nephropathy (including dialysis or renal transplantation), neuropathy (lower limb pain or sensibility problems/ulcer/amputation), severe hypo or hyperglycemia.
* Myocardial infarction/angina, stroke, neuropathy (lower limb pain or sensibility problems/ulcer/amputation).
** Retinopathy, nephropathy (including dialysis or renal transplantation).